NCT04491643 2025-08-11
Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma
Fudan University
Phase 2 Completed
Clinical Trials
9 trialsNCT04542382 2025-03-30
BCRPmarker
University of California, San Francisco
Phase 1 Completed
NCT03532139 2025-01-23
Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study)
Beth Israel Deaconess Medical Center
Phase 2 Completed
NCT05338723 2024-02-28
Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer Patients
Tanta University
Phase 3 Completed
NCT02569645 2022-07-20
Rosuvastatin in the Treatment of Rectal Cancer
AHS Cancer Control Alberta
Phase 2 Completed
NCT04776889 2021-03-02
The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients
National Cancer Institute, Egypt
Phase 4 Completed
NCT00966472 2020-04-21
Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC
Ottawa Hospital Research Institute
Phase 1 Completed
NCT01299038 2020-02-05
Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer
Dana-Farber Cancer Institute
Phase 2 Completed
NCT01524653 2018-07-10
DISOLVE
University of Vermont
Phase 2 Completed